Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Empty Capsule Market

ID: MRFR/Pharma/47494-HCR
200 Pages
Rahul Gotadki
Last Updated: April 24, 2026
France Empty Capsule Market Research Report By Type (Gelatin Capsules, Vegetarian Capsules), By Functionality (Fast-release Capsules, Slow-release Capsules), By Physical Characteristics (Halal, Non-Halal), By Form (Hard Capsules, Soft Capsules), By Appearance (Transparent, Opaque) and By Application (Pharmaceutical, Nutraceutical) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Million)
      1. 4.1.1 Gelatin Capsules
      2. 4.1.2 Vegetarian Capsules
    2. 4.2 Healthcare, BY Functionality (USD Million)
      1. 4.2.1 Fast-release Capsules
      2. 4.2.2 Slow-release Capsules
    3. 4.3 Healthcare, BY Physical Characteristics (USD Million)
      1. 4.3.1 Halal
      2. 4.3.2 Non-Halal
    4. 4.4 Healthcare, BY Form (USD Million)
      1. 4.4.1 Hard Capsules
      2. 4.4.2 Soft Capsules
    5. 4.5 Healthcare, BY Appearance (USD Million)
      1. 4.5.1 Transparent
      2. 4.5.2 Opaque
    6. 4.6 Healthcare, BY Application (USD Million)
      1. 4.6.1 Pharmaceutical
      2. 4.6.2 Nutraceutical
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Capsugel (BE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Qualicaps (JP)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 ACG Worldwide (IN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Suheung Co Ltd (KR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Lonza Group (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Famar (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medisca (CA)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Roxlor (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Ginkgo BioWorks (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 FRANCE MARKET ANALYSIS BY TYPE
    3. 6.3 FRANCE MARKET ANALYSIS BY FUNCTIONALITY
    4. 6.4 FRANCE MARKET ANALYSIS BY PHYSICAL CHARACTERISTICS
    5. 6.5 FRANCE MARKET ANALYSIS BY FORM
    6. 6.6 FRANCE MARKET ANALYSIS BY APPEARANCE
    7. 6.7 FRANCE MARKET ANALYSIS BY APPLICATION
    8. 6.8 KEY BUYING CRITERIA OF HEALTHCARE
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF HEALTHCARE
    11. 6.11 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    13. 6.13 SUPPLY / VALUE CHAIN: HEALTHCARE
    14. 6.14 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY FUNCTIONALITY, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY FUNCTIONALITY, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY PHYSICAL CHARACTERISTICS, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY PHYSICAL CHARACTERISTICS, 2024 TO 2035 (USD Million)
    20. 6.20 HEALTHCARE, BY FORM, 2024 (% SHARE)
    21. 6.21 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Million)
    22. 6.22 HEALTHCARE, BY APPEARANCE, 2024 (% SHARE)
    23. 6.23 HEALTHCARE, BY APPEARANCE, 2024 TO 2035 (USD Million)
    24. 6.24 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    25. 6.25 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY FUNCTIONALITY, 2025-2035 (USD Million)
      3. 7.2.3 BY PHYSICAL CHARACTERISTICS, 2025-2035 (USD Million)
      4. 7.2.4 BY FORM, 2025-2035 (USD Million)
      5. 7.2.5 BY APPEARANCE, 2025-2035 (USD Million)
      6. 7.2.6 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

France Healthcare Market Segmentation

Healthcare By Type (USD Million, 2025-2035)

  • Gelatin Capsules
  • Vegetarian Capsules

Healthcare By Functionality (USD Million, 2025-2035)

  • Fast-release Capsules
  • Slow-release Capsules

Healthcare By Physical Characteristics (USD Million, 2025-2035)

  • Halal
  • Non-Halal

Healthcare By Form (USD Million, 2025-2035)

  • Hard Capsules
  • Soft Capsules

Healthcare By Appearance (USD Million, 2025-2035)

  • Transparent
  • Opaque

Healthcare By Application (USD Million, 2025-2035)

  • Pharmaceutical
  • Nutraceutical